Cargando…

Plant-produced Microbial Vaccines

In recent years, plants have been increasingly explored for production of biomedicines and vaccine components. The two main advantages of plant systems are low cost and a greater potential for scalability as compared to microbial or animal systems. An additional advantage from the public health poin...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Karasev, Alexander V. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2009.
Edición:1st ed. 2009.
Colección:Current Topics in Microbiology and Immunology, 332
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-540-70868-1
003 DE-He213
005 20220118071206.0
007 cr nn 008mamaa
008 100301s2009 gw | s |||| 0|eng d
020 |a 9783540708681  |9 978-3-540-70868-1 
024 7 |a 10.1007/978-3-540-70868-1  |2 doi 
050 4 |a RM300-666 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
072 7 |a MKG  |2 thema 
082 0 4 |a 615  |2 23 
245 1 0 |a Plant-produced Microbial Vaccines  |h [electronic resource] /  |c edited by Alexander V. Karasev. 
250 |a 1st ed. 2009. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2009. 
300 |a X, 120 p. 26 illus., 10 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Topics in Microbiology and Immunology,  |x 2196-9965 ;  |v 332 
505 0 |a Plant Vaccines: An Immunological Perspective -- Display of Peptides on the Surface of Tobacco Mosaic Virus Particles -- Chloroplast-Derived Vaccine Antigens and Biopharmaceuticals: Expression, Folding, Assembly and Functionality -- Production of Antibodies in Plants: Approaches and Perspectives -- Plant Production of Veterinary Vaccines and Therapeutics -- Plant-Based Oral Vaccines: Results of Human Trials. 
520 |a In recent years, plants have been increasingly explored for production of biomedicines and vaccine components. The two main advantages of plant systems are low cost and a greater potential for scalability as compared to microbial or animal systems. An additional advantage from the public health point of view is high safety compared to animal systems, which is important for vaccine production: there are no known plant pathogens capable of replicating in animals, and in humans in particular. A particular antigen or a protein has to be expressed in a plant using one of many available platforms; this antigen/protein subsequently needs to be purified or processed, and later formulated into a vaccine or a therapeutic; these need to be delivered to a human or animal body via an appropriate route. Naturally, all these vaccines and therapeutics must be subjected to regulatory approvals prior to their use. Thus, the challenge is to adapt plant-based platforms for production of cost-efficient biomedicals that can be approved by FDA for use as vaccine components or therapeutics which will be competitive against existing vaccines and drugs. Production of vaccine components and other biomedicals in plants has a great potential in medicine and veterinary science. 
650 0 |a Pharmacology. 
650 0 |a Virology. 
650 0 |a Medical microbiology. 
650 1 4 |a Pharmacology. 
650 2 4 |a Virology. 
650 2 4 |a Medical Microbiology. 
700 1 |a Karasev, Alexander V.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783642089831 
776 0 8 |i Printed edition:  |z 9783540867098 
776 0 8 |i Printed edition:  |z 9783540708575 
830 0 |a Current Topics in Microbiology and Immunology,  |x 2196-9965 ;  |v 332 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-540-70868-1  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)